Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T19011 | Target Info | |||
Target Name | M-phase inducer phosphatase 3 (MPIP3) | ||||
Synonyms | Dual specificity phosphatase Cdc25C; Cdc25C phosphatase | ||||
Target Type | Literature-reported Target | ||||
Gene Name | CDC25C | ||||
Biochemical Class | Phosphoric monoester hydrolase | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | [(1S,5R,9R,16S,20S,24R,28R,35S)-22-phosphonooxy-3-tridecacyclo[22.14.1.15,20.19,16.128,35.02,23.04,21.06,19.08,17.010,15.025,38.027,36.029,34]dotetraconta-2,4(21),6(19),7,10,12,14,17,22,25(38),26,29,31,33,36-pentadecaenyl] dihydrogen phosphate | Ligand Info | |||
Canonical SMILES | C1C2C3=CC=CC=C3C1C4=CC5=C(C=C24)C6CC5C7=C6C(=C8C9CC(C8=C7OP(=O)(O)O)C1=C9C=C2C3CC(C2=C1)C1=CC=CC=C31)OP(=O)(O)O | ||||
InChI | 1S/C42H32O8P2/c43-51(44,45)49-41-37-33-15-34(30-12-26-22-9-21(25(26)11-29(30)33)17-5-1-2-6-18(17)22)38(37)42(50-52(46,47)48)40-36-16-35(39(40)41)31-13-27-23-10-24(28(27)14-32(31)36)20-8-4-3-7-19(20)23/h1-8,11-14,21-24,33-36H,9-10,15-16H2,(H2,43,44,45)(H2,46,47,48)/t21-,22+,23+,24-,33-,34+,35+,36- | ||||
InChIKey | BZESKQAEKFQSPD-FCODNRGNSA-N | ||||
PubChem Compound ID | 25023394 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 5M36 The molecular tweezer CLR01 stabilizes a disordered protein-protein interface | ||||||
Method | X-ray diffraction | Resolution | 2.45 Å | Mutation | No | [1] |
PDB Sequence |
SRSGLYRSPM
217 PENLNRPR
|
|||||
|
||||||
PDB ID: 5M37 The molecular tweezer CLR01 stabilizes a disordered protein-protein interface | ||||||
Method | X-ray diffraction | Resolution | 2.35 Å | Mutation | No | [1] |
PDB Sequence |
SRSGLYRSPM
217 PENLNRP
|
|||||
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | The Molecular Tweezer CLR01 Stabilizes a Disordered Protein-Protein Interface. J Am Chem Soc. 2017 Nov 15;139(45):16256-16263. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.